QNST:NASDAQQuinStreet, Inc. Analysis
Data as of 2026-06-17 - not real-time
$12.95
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
QuinStreet trades at $12.95, comfortably above its 20‑day ($12.16) and 50‑day ($12.40) moving averages but still below the 200‑day SMA ($13.53), indicating short‑term momentum in a longer‑term downtrend. The RSI of 60 and a bullish MACD histogram (+0.098) suggest the stock retains some upside momentum, while decreasing volume and a bearish trend direction flag potential short‑term weakness near the $12.98 resistance level. On the valuation side, the forward PE of 8.5 and a trailing PE of 11.6 are well under the industry average PE of 17.1, positioning QNST as a clear value play. Revenue surged 28% year‑over‑year to $1.18 B, yet margins remain thin (gross 10.5%, operating 3.9%), highlighting a growth story that is still profit‑constrained. The balance sheet is strong with $102 M cash against $78 M debt (debt‑to‑equity 25%), and ROE stands at an impressive 24%, supporting the analyst consensus of a "strong buy" and a median target of $17.
The market’s extreme greed sentiment (92 on the Fear & Greed Index) and a DCF‑derived fair value of $68.6 imply a massive upside potential, though the 30‑day volatility of 53% and a beta near 1 signal heightened price swings. With no dividend and a payout ratio of zero, investors must rely on capital appreciation. Overall, the stock appears significantly undervalued relative to peers, but investors should monitor the near‑term resistance, volume trends, and broader advertising sector cycles.
The market’s extreme greed sentiment (92 on the Fear & Greed Index) and a DCF‑derived fair value of $68.6 imply a massive upside potential, though the 30‑day volatility of 53% and a beta near 1 signal heightened price swings. With no dividend and a payout ratio of zero, investors must rely on capital appreciation. Overall, the stock appears significantly undervalued relative to peers, but investors should monitor the near‑term resistance, volume trends, and broader advertising sector cycles.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near $12.98 resistance
- Decreasing trading volume
- Bearish longer‑term trend despite bullish MACD
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 28% revenue growth
- Forward PE of 8.5 and strong analyst "strong buy" rating
- Undervalued relative to industry PE and DCF upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- DCF fair value indicating ~46% upside
- High ROE (24%) and low debt levels
- Sustained cash generation and expanding performance‑marketing platform
Key Metrics & Analysis
Financial Health
Revenue Growth28.30%
Profit Margin5.53%
P/E Ratio11.6
ROE23.94%
ROA3.68%
Debt/Equity25.26
P/B Ratio2.4
Op. Cash Flow$108.1M
Free Cash Flow$108.5M
Industry P/E17.1
Technical Analysis
TrendBearish
RSI60.2
Support$11.02
Resistance$12.98
MA 20$12.16
MA 50$12.40
MA 200$13.53
MACDBullish
VolumeDecreasing
Fear & Greed Index92.02
Valuation
Fair Value$68.62
Target Price$19.00
Upside/Downside46.72%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.02
Volatility53.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.